Award
NIH Reporter #1R01CA291848-01A1
Targeting EZH2 in advanced prostate cancer
Recipient
National Cancer Institute (NCI)
Award Amount
$497,972.00
Ceiling
$497,972.00
Awarded
March 30, 2026
Identifier
1R01CA291848-01A1
Research project awarded to investigate and develop novel EZH2-targeting therapies for advanced prostate cancer using PROTAC technology.
Description
The project focuses on investigating non-canonical functions of EZH2 in prostate cancer. The research involves developing EZH2 small-molecule degraders using PROTAC technology. The project aims to provide a novel therapeutic strategy for advanced prostate cancer.